Evi Kostenis

Title: Evi Kostenis: Innovator in Medicinal Chemistry

Introduction

Evi Kostenis is a notable inventor based in Hoersholm, Denmark. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target the CRTH2 receptor. His work is essential for advancing treatments for various allergic conditions.

Latest Patents

Evi Kostenis holds a patent for "CRTH2 receptor ligands for medicinal uses." This patent describes compounds that are useful for treating diseases responsive to modulation of CRTH2 receptor activity, such as asthma, rhinitis, allergic airway syndrome, and allergic rhinobronchitis. The compounds are characterized by a specific formula, where A represents a carboxyl group or a carboxyl bioisostere, and various ring structures are defined to enhance their medicinal properties. He has 1 patent in this area.

Career Highlights

Evi Kostenis is currently associated with 7Tm Pharma A/S, where he continues to innovate in the field of pharmacology. His research focuses on developing new therapeutic options that can significantly improve patient outcomes in allergic diseases.

Collaborations

Evi has collaborated with notable colleagues, including Trond Ulven and Marie Grimstrup, who contribute to the research and development efforts at 7Tm Pharma A/S.

Conclusion

Evi Kostenis is a prominent figure in medicinal chemistry, with a focus on CRTH2 receptor ligands that hold promise for treating allergic conditions. His work exemplifies the impact of innovative research in improving healthcare solutions.